179 related articles for article (PubMed ID: 34326467)
21. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
[TBL] [Abstract][Full Text] [Related]
22. SMAD4 suppresses AURKA-induced metastatic phenotypes via degradation of AURKA in a TGFβ-independent manner.
Jia L; Lee HS; Wu CF; Kundu J; Park SG; Kim RN; Wang LH; Erkin ÖC; Choi JS; Chae SW; Yang HB; Choi YL; Shin YK
Mol Cancer Res; 2014 Dec; 12(12):1779-95. PubMed ID: 25061104
[TBL] [Abstract][Full Text] [Related]
23. Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype.
Zheng F; Yue C; Li G; He B; Cheng W; Wang X; Yan M; Long Z; Qiu W; Yuan Z; Xu J; Liu B; Shi Q; Lam EW; Hung MC; Liu Q
Nat Commun; 2016 Jan; 7():10180. PubMed ID: 26782714
[TBL] [Abstract][Full Text] [Related]
24. Activation of the FAK/PI3K pathway is crucial for AURKA-induced epithelial-mesenchymal transition in laryngeal cancer.
Yang L; Zhou Q; Chen X; Su L; Liu B; Zhang H
Oncol Rep; 2016 Aug; 36(2):819-26. PubMed ID: 27373675
[TBL] [Abstract][Full Text] [Related]
25. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
[TBL] [Abstract][Full Text] [Related]
26. Aurora Kinase A is critical for the Nkx6.1 mediated β-cell proliferation pathway.
Hobson A; Draney C; Stratford A; Becker TC; Lu D; Arlotto M; Tessem JS
Islets; 2015; 7(1):e1027854. PubMed ID: 26030060
[TBL] [Abstract][Full Text] [Related]
27. STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells.
Pawlus MR; Wang L; Hu CJ
Oncogene; 2014 Mar; 33(13):1670-9. PubMed ID: 23604114
[TBL] [Abstract][Full Text] [Related]
28. Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells.
Katsha A; Wang L; Arras J; Omar OM; Ecsedy J; Belkhiri A; El-Rifai W
Clin Cancer Res; 2017 Jul; 23(14):3756-3768. PubMed ID: 28073841
[No Abstract] [Full Text] [Related]
29. Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.
Jones BC; Kelley LC; Loskutov YV; Marinak KM; Kozyreva VK; Smolkin MB; Pugacheva EN
Mol Cancer Res; 2017 Jun; 15(6):670-682. PubMed ID: 28235899
[TBL] [Abstract][Full Text] [Related]
30. Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion.
Do TV; Xiao F; Bickel LE; Klein-Szanto AJ; Pathak HB; Hua X; Howe C; O'Brien SW; Maglaty M; Ecsedy JA; Litwin S; Golemis EA; Schilder RJ; Godwin AK; Connolly DC
Oncogene; 2014 Jan; 33(5):539-49. PubMed ID: 23334327
[TBL] [Abstract][Full Text] [Related]
31. Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients.
Siggelkow W; Boehm D; Gebhard S; Battista M; Sicking I; Lebrecht A; Solbach C; Hellwig B; Rahnenführer J; Koelbl H; Gehrmann M; Marchan R; Cadenas C; Hengstler JG; Schmidt M
BMC Cancer; 2012 Nov; 12():562. PubMed ID: 23186136
[TBL] [Abstract][Full Text] [Related]
32. PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes.
Ponente M; Campanini L; Cuttano R; Piunti A; Delledonne GA; Coltella N; Valsecchi R; Villa A; Cavallaro U; Pattini L; Doglioni C; Bernardi R
JCI Insight; 2017 Feb; 2(4):e87380. PubMed ID: 28239645
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation-dependent regulation of ALDH1A1 by Aurora kinase A: insights on their synergistic relationship in pancreatic cancer.
Wang J; Nikhil K; Viccaro K; Chang L; White J; Shah K
BMC Biol; 2017 Feb; 15(1):10. PubMed ID: 28193222
[TBL] [Abstract][Full Text] [Related]
34. The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer.
Lin A; Li C; Xing Z; Hu Q; Liang K; Han L; Wang C; Hawke DH; Wang S; Zhang Y; Wei Y; Ma G; Park PK; Zhou J; Zhou Y; Hu Z; Zhou Y; Marks JR; Liang H; Hung MC; Lin C; Yang L
Nat Cell Biol; 2016 Feb; 18(2):213-24. PubMed ID: 26751287
[TBL] [Abstract][Full Text] [Related]
35. AurkA controls self-renewal of breast cancer-initiating cells promoting wnt3a stabilization through suppression of miR-128.
Eterno V; Zambelli A; Villani L; Tuscano A; Manera S; Spitaleri A; Pavesi L; Amato A
Sci Rep; 2016 Jun; 6():28436. PubMed ID: 27341528
[TBL] [Abstract][Full Text] [Related]
36. Polymer Nanovesicle-Mediated Delivery of MLN8237 Preferentially Inhibits Aurora Kinase A To Target RalA and Anchorage-Independent Growth in Breast Cancer Cells.
Inchanalkar S; Deshpande NU; Kasherwal V; Jayakannan M; Balasubramanian N
Mol Pharm; 2018 Aug; 15(8):3046-3059. PubMed ID: 29863884
[TBL] [Abstract][Full Text] [Related]
37. Suppression of tumor growth by designed dimeric epidithiodiketopiperazine targeting hypoxia-inducible transcription factor complex.
Dubey R; Levin MD; Szabo LZ; Laszlo CF; Kushal S; Singh JB; Oh P; Schnitzer JE; Olenyuk BZ
J Am Chem Soc; 2013 Mar; 135(11):4537-49. PubMed ID: 23448368
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target.
Richard F; De Schepper M; Maetens M; Leduc S; Isnaldi E; Geukens T; Van Baelen K; Nguyen HL; Vermeulen P; Van Laere S; Bertucci F; Ueno N; Dirix L; Floris G; Biganzoli E; Desmedt C
Breast; 2023 Jun; 69():476-480. PubMed ID: 36717329
[TBL] [Abstract][Full Text] [Related]
39. Ca2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia.
Yuan G; Nanduri J; Bhasker CR; Semenza GL; Prabhakar NR
J Biol Chem; 2005 Feb; 280(6):4321-8. PubMed ID: 15569687
[TBL] [Abstract][Full Text] [Related]
40. Up-regulated HIF-2α contributes to the Osteoarthritis development through mediating the primary cilia loss.
Yang Q; Zhou Y; Cai P; Fu W; Wang J; Wei Q; Li X
Int Immunopharmacol; 2019 Oct; 75():105762. PubMed ID: 31357086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
